Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis

  1. Kalincik, T.
  2. Kubala Havrdova, E.
  3. Horakova, D.
  4. Izquierdo, G.
  5. Prat, A.
  6. Girard, M.
  7. Duquette, P.
  8. Grammond, P.
  9. Onofrj, M.
  10. Lugaresi, A.
  11. Ozakbas, S.
  12. Kappos, L.
  13. Kuhle, J.
  14. Terzi, M.
  15. Lechner-Scott, J.
  16. Boz, C.
  17. Grand'maison, F.
  18. Prevost, J.
  19. Sola, P.
  20. Ferraro, D.
  21. Granella, F.
  22. Trojano, M.
  23. Bergamaschi, R.
  24. Pucci, E.
  25. Turkoglu, R.
  26. McCombe, P.A.
  27. Pesch, V.V.
  28. Van Wijmeersch, B.
  29. Solaro, C.
  30. Ramo-Tello, C.
  31. Slee, M.
  32. Alroughani, R.
  33. Yamout, B.
  34. Shaygannejad, V.
  35. Spitaleri, D.
  36. Sánchez-Menoyo, J.L.
  37. Ampapa, R.
  38. Hodgkinson, S.
  39. Karabudak, R.
  40. Butler, E.
  41. Vucic, S.
  42. Jokubaitis, V.
  43. Spelman, T.
  44. Butzkueven, H.
  45. Show all authors +
Journal:
Journal of Neurology, Neurosurgery and Psychiatry

ISSN: 1468-330X 0022-3050

Year of publication: 2019

Volume: 90

Issue: 4

Pages: 458-468

Type: Article

DOI: 10.1136/JNNP-2018-319831 GOOGLE SCHOLAR

Sustainable development goals